Literature DB >> 23867667

Over-expression of gene encoding heat shock protein 70 from Mycobacterium tuberculosis and its evaluation as vaccine adjuvant.

J Dhakal1, G S Brah, R K Agrawal, H N Pawar, D Kaur, R Verma.   

Abstract

BACKGROUND: Heat shock proteins (Hsps) are evolutionary ancient and highly conserved molecular chaperons found in prokaryotes as well as eukaryotes. Hsp70 is a predominant member of Hsp family. Microbial Hsp70s (mHsp70s) have acquired special significance in immunity since they have been shown to be potent activators of the innate immune system and generate specific immune responses against tumours and infectious agents.
OBJECTIVES: The present study was aimed to clone express and purify recombinant Hsp70 from the Mycobacterium tuberculosis and characterise it immunologically. The study also aimed at determining the potential of recombinant M. tuberculosis heat shock protein (rMTB-Hsp70) as adjuvant or antigen carrier.
MATERIALS AND METHODS: Cloning of M. tuberculosis heat shock protein (MTB-Hsp70) amplicon was carried out using the pGEMT-Easy vector although for expression, pProExHTb prokaryotic expression vector was used. Purification of recombinant Hsp70 was carried out by nickel-nitrilotriacetic acid (Ni-NTA) affinity chromatography. For immunological characterization and determining the adjuvant effect of MTB-Hsp70, BALB/c mice were used. The data obtained was statistically analysed.
RESULTS: Hsp70 gene was cloned, sequenced and the sequence data were submitted to National Center for Biotechnology Information (NCBI). Recombinant MTB-Hsp70 was successfully over-expressed using the prokaryotic expression system and purified to homogeneity. The protein was found to be immunodominant. Significant adjuvant effect was produced by the rMTB-Hsp70 when inoculated with recombinant outer membrane protein 31; however, effect was less than the conventionally used the Freund's adjuvant.
CONCLUSION: Protocol standardised can be followed for bulk production of rHsp70 in a cost-effective manner. Significant adjuvant effect was produced by rMTB-Hsp70; however, the effect was than Freund's adjuvant. Further, studies need to be carried out to explore its applicability as carrier of antigen.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23867667     DOI: 10.4103/0255-0857.115222

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  5 in total

1.  Evaluation of immuno-modulating effect of recombinant heat shock protein 40 of Brucella abortus in mice.

Authors:  Priyanka Minhas; B V Sunil Kumar; Ramneek Verma
Journal:  3 Biotech       Date:  2019-09-23       Impact factor: 2.406

2.  Expression of recombinant DnaK of Brucella abortus and its evaluation as immuno-modulator.

Authors:  Priyanka Minhas; B V Sunil Kumar; Ramneek Verma
Journal:  Arch Microbiol       Date:  2021-02-19       Impact factor: 2.552

Review 3.  Using PAMPs and DAMPs as adjuvants in cancer vaccines.

Authors:  Huanyou Sun; Wenwen Hu; Yinan Yan; Zichun Zhang; Yuxin Chen; Xuefan Yao; Ling Teng; Xinyuan Wang; Dafei Chai; Junnian Zheng; Gang Wang
Journal:  Hum Vaccin Immunother       Date:  2021-09-14       Impact factor: 4.526

4.  In silico design of a multi-epitope vaccine against HPV16/18.

Authors:  Samira Sanami; Mahmoud Rafieian-Kopaei; Korosh Ashrafi Dehkordi; Hamidreza Pazoki-Toroudi; Fatemeh Azadegan-Dehkordi; Gholam-Reza Mobini; Morteza Alizadeh; Muhammad Sadeqi Nezhad; Maryam Ghasemi-Dehnoo; Nader Bagheri
Journal:  BMC Bioinformatics       Date:  2022-08-02       Impact factor: 3.307

5.  A Recombinant Trivalent Fusion Protein F1-LcrV-HSP70(II) Augments Humoral and Cellular Immune Responses and Imparts Full Protection against Yersinia pestis.

Authors:  Shailendra K Verma; Lalit Batra; Urmil Tuteja
Journal:  Front Microbiol       Date:  2016-07-05       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.